Clinical trial
Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
NCT00431808 · African Malaria Network Trust, Other · Unknown status
Key facts
| NCT number | NCT00431808 |
|---|---|
| Title | Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]) |
| Official title | Randomized Controlled Trial to Evaluate the Safety and Immunogenicity of Recombinant Pichia Pastoris-Expressed P. Falciparum Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]) Versus Tetanus Toxoid, in Healthy Malian Adult in Bandiagara |
| Lead sponsor | African Malaria Network Trust, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | Malaria vaccine AMA1 (PfAMA-1-FVO[25-545], AMA1 |
| Enrollment | 40 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 6, 2007 |
| Last update posted | Apr 3, 2008 |
| Countries | Mali |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: